Bangor Daily News

Novel mRNA cancer vaccine helps cut chances of tumors returning in melanoma patients

Moderna and Merck’s innovative personalized mRNA cancer vaccine significantly reduces the risk of melanoma recurrence, offering a groundbreaking new frontier in the fight against various forms of…

Read the original at Bangor Daily News

More audio from Bangor Daily News